Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Express Scripts
QuintilesIMS
Medtronic
McKinsey

Generated: May 22, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN DEGLUDEC; LIRAGLUTIDE

« Back to Dashboard

INSULIN DEGLUDEC; LIRAGLUTIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583 NDA Novo Nordisk 0169-2911-15 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) > 3 mL in 1 SYRINGE, PLASTIC
Novo XULTOPHY 100/3.6 insulin degludec; liraglutide SOLUTION;SUBCUTANEOUS 208583 NDA Novo Nordisk 0169-2911-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2911-97) > 3 mL in 1 SYRINGE, PLASTIC (0169-2911-90)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Cantor Fitzgerald
Merck
Deloitte
Colorcon